The eyes have it

Lifeblood is excited to announce the launch of our new allogeneic serum eyedrops (AlloSED) commencing February 2026.

Manufactured from the generous donations of our male Group AB donors and delivered directly to the patient – our new AlloSED product and service model makes serum eyedrops more efficient to produce, and available to more patients nationally. 

AlloSED have been approved by both the Therapeutic Goods Administration and the National Blood Authority and will replace our current autologous product.

Further information will be available soon for ophthalmologists. 

Patients should contact their ophthalmologist in the first instance.